A carregar...

Prostate Cancer Clinical Trial End Points: ‘‘RECIST’’ing a Step Backwards

PURPOSE: To relate clinical issues to the clinical manifestations of prostate cancers across disease states using the eligibility and outcome criteria defined by Response Evaluation Criteria in Solid Tumors (RECIST). EXPERIMENTAL DESIGN: The manifestations of prostate cancer that characterize locali...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scher, Howard I., Morris, Michael J., Kelly, William K., Schwartz, Lawrence H., Heller, Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1852496/
https://ncbi.nlm.nih.gov/pubmed/16033840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-05-0109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!